Literature DB >> 17393935

Intravenous perfluorocarbon emulsion increases nitrogen washout after venous gas emboli in rabbits.

J Zhu1, J B Hullett, L Somera, R W Barbee, K R Ward, B E Berger, B D Spiess.   

Abstract

Intravenous perfluorocarbon emulsion (IV-PFC) has been shown to provide hemodynamic protection from gas embolism (Venous-VGE or arterial-AGE). The objective of this study was to investigate the mechanism of PFC protection from controlled VGE by quantifying the effects of IV-PFC emulsion on pulmonary elimination of nitrogen (N2). All rabbits received an intravenous pretreatment of PFC emulsion (Oxygent, 2.7 g/kg) or saline, then either a continuous room air infusion (0.25 ml/kg for 10 minutes) or a bolus of air (0.8 ml/kg within 10 seconds) through the femoral vein. Expiratory N2 peaked higher with PFC infusion immediately after air injection. The recovery to baseline of end tidal N2 was faster for PFC-treated animals (40 +/- 4.7 vs. 58 +/- 6.5 minutes). In PFC-treated animals, expired CO2, O2, arterial pressure and central venous pressure returned to baseline faster than the saline group. This study demonstrated that PFC increased pulmonary N2 washout. Correspondingly, PFC treatment better preserved the animals' hemodynamics after VGE injury. The use of IV-PFC promises to be a breakthrough non-recompression therapy for gas embolism in the treatment of Decompression Sickness (DCS) and in surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393935

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  4 in total

1.  Treatment of micro air bubbles in rat adipose tissue at 25 kPa altitude exposures with perfluorocarbon emulsions and nitric oxide.

Authors:  Thomas Randsøe; O Hyldegaard
Journal:  Eur J Appl Physiol       Date:  2013-10-25       Impact factor: 3.078

2.  The intravenous perfluorocarbon emulsion Oxycyte does not increase hyperbaric oxygen-related seizures in a non-sedated swine model.

Authors:  Richard T Mahon; Aaron Hall; Michael Bodo; Charles Auker
Journal:  Eur J Appl Physiol       Date:  2013-09-06       Impact factor: 3.078

Review 3.  Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice.

Authors:  Dirk Mayer; Katja Bettina Ferenz
Journal:  Eur J Appl Physiol       Date:  2019-11-04       Impact factor: 3.078

Review 4.  Perfluorocarbon-based oxygen carriers: from physics to physiology.

Authors:  Johannes Jägers; Anna Wrobeln; Katja B Ferenz
Journal:  Pflugers Arch       Date:  2020-11-03       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.